Economic Calendar

Thursday, October 16, 2008

Accor, EDF, Remy Cointreau, Stallergenes: French Stocks Preview

Share this history on :

By Andrea Rothman

Oct. 16 (Bloomberg) -- The following is a list of companies whose stocks may have unusual changes in Paris. Symbols are in parentheses after company names and prices are from the last close.

France's CAC 40 Index dropped 247.45, or 6.8 percent, to 3,381.07 in Paris after a 14 percent two-day gain. The SBF 120 Index lost 6.7 percent.

Accor SA (AC FP): Europe's biggest hotelier reports third- quarter revenue after the market close in Paris. Sales probably slid 3.8 percent to 2.02 billion euros, according to the median of eight analyst estimates, after the company sold its Go Voyages unit and as fewer travelers stayed at Accor's mid-scale properties. The shares lost 3.60 euros, or 10 percent, to 32 euros.

Cegid Group SA (CGD FP): The accounting software designer reported a 0.7 percent drop in third-quarter revenue to 53.8 million euros and forecast ``no fundamental change'' in full- year operating earnings. The shares fell 51 cents, or 3.9 percent, to 12.49 euros.

Electricite de France SA (EDF FP), the world's biggest operator of nuclear reactors, said it won't make a new takeover offer for Constellation Energy Group Inc., citing a ``difficult'' credit market. The shares fell 2.82 euros, or 6.5 percent, to 40.81 euros.

Remy Cointreau SA (RCO FP): France's second-largest liquor company reports first-half sales before the market opens in Paris. Revenue dropped 3.6 percent to 360.9 million euros, according to the median of five analyst estimates, after the company ended contracts to distribute lower-priced beverages and U.S. cognac demand weakened. The shares dropped 1 euro, or 3.6 percent, to 26.84 euros.

Sperian Protection SA (SPR FP): The world's biggest maker of equipment for work safety said third-quarter revenue fell 9.6 percent to 174.8 million euros and cut its full-year sales growth forecast. The shares lost 1.62 euros, or 2.4 percent, to 65.73 euros.

Stallergenes SA (GENP FP): Europe's second-largest maker of allergy drugs reported a 17 percent rise in third-quarter sales to 34.2 million euros and raised its full-year revenue growth forecast to ``about'' 14 percent. The shares fell 2.13 euros, or 5.2 percent, to 38.67 euros.

Vet' Affaires SA (VET FP): The discount clothing retailer reported third-quarter revenue of 25.6 million euros, up fro 25.2 million euros a year earlier and forecast full-year sales of more than 95 million euros. The shares dropped 1.10 euros, or 11 percent, to 8.80 euros.

To contact the reporter on this story: Andrea Rothman in Paris at aerothman@bloomberg.net.


No comments: